Literature DB >> 12034442

Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.

Steffen Schlehuber1, Arne Skerra.   

Abstract

Anticalins are prepared by reshaping the ligand pocket of a natural lipocalin via protein engineering in order to recognize a prescribed ligand. In this manner, the anticalin DigA with specificity for digoxigenin was previously derived from the bilin-binding protein (BBP), a natural lipocalin from Pieris brassicae. The four peptide loops that form its ligand-binding site were randomized and a cognate variant was selected from the resulting library. Here, we propose a concept for improving the ligand-binding properties of this anticalin in an in vitro affinity maturation process by step-wise randomization of restricted areas of the loop region. Following selection on digoxigenin-binding activity via phage display and colony screening, several DigA variants were thus obtained. The recombinant proteins were thoroughly characterized in terms of ligand affinity and specificity, secondary structure and thermal stability against unfolding. The variant DigA16/19, which carries several new mutations, exhibits clearly improved affinity for digoxigenin, with K(D)=12.4 nM. Hence, it is suitable as a sensitive reagent in biochemical detection experiments, especially when produced as a functional fusion protein with alkaline phosphatase as reporter enzyme. In addition, DigA16/19 possesses enhanced ligand specificity and recognizes part of the linker that was used for fixing the steroid group to a carrier protein. Finally, the digoxigenin-binding anticalins appear to have high physico-chemical stability, with T(m) values in the 70 degrees C range. Our present findings support the notion that anticalins provide a useful class of compact and robust ligand-receptor proteins that can be tailored for practical demands.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034442     DOI: 10.1016/s0301-4622(02)00026-1

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  12 in total

1.  Steered molecular dynamics simulations of ligand-receptor interaction in lipocalins.

Authors:  Janne Kalikka; Jaakko Akola
Journal:  Eur Biophys J       Date:  2010-11-13       Impact factor: 1.733

2.  Biochemical analysis of recombinant AlkJ from Pseudomonas putida reveals a membrane-associated, flavin adenine dinucleotide-dependent dehydrogenase suitable for the biosynthetic production of aliphatic aldehydes.

Authors:  Ludwig Kirmair; Arne Skerra
Journal:  Appl Environ Microbiol       Date:  2014-02-07       Impact factor: 4.792

3.  Modification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.

Authors:  Tiina A Riihimäki; Soili Hiltunen; Martina Rangl; Henri R Nordlund; Juha A E Määttä; Andreas Ebner; Peter Hinterdorfer; Markku S Kulomaa; Kristiina Takkinen; Vesa P Hytönen
Journal:  BMC Biotechnol       Date:  2011-06-09       Impact factor: 2.563

4.  New binding mode to TNF-alpha revealed by ubiquitin-based artificial binding protein.

Authors:  Andreas Hoffmann; Michael Kovermann; Hauke Lilie; Markus Fiedler; Jochen Balbach; Rainer Rudolph; Sven Pfeifer
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

5.  NMR structure of lipoprotein YxeF from Bacillus subtilis reveals a calycin fold and distant homology with the lipocalin Blc from Escherichia coli.

Authors:  Yibing Wu; Marco Punta; Rong Xiao; Thomas B Acton; Bharathwaj Sathyamoorthy; Fabian Dey; Markus Fischer; Arne Skerra; Burkhard Rost; Gaetano T Montelione; Thomas Szyperski
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

6.  Rationally designing aptamer sequences with reduced affinity for controlled sensor performance.

Authors:  Lauren R Schoukroun-Barnes; Ryan J White
Journal:  Sensors (Basel)       Date:  2015-03-31       Impact factor: 3.576

7.  PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins.

Authors:  Martin Schlapschy; Uli Binder; Claudia Börger; Ina Theobald; Klaus Wachinger; Sigrid Kisling; Dirk Haller; Arne Skerra
Journal:  Protein Eng Des Sel       Date:  2013-06-10       Impact factor: 1.650

8.  High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.

Authors:  Sabine Rauth; Dominik Hinz; Michael Börger; Markus Uhrig; Manuel Mayhaus; Matthias Riemenschneider; Arne Skerra
Journal:  Biochem J       Date:  2016-03-30       Impact factor: 3.857

9.  Engineering a Highly Active Sucrose Isomerase for Enhanced Product Specificity by Using a "Battleship" Strategy.

Authors:  Patrick Pilak; André Schiefner; Judith Seiboth; Johannes Oehrlein; Arne Skerra
Journal:  Chembiochem       Date:  2020-04-16       Impact factor: 3.164

10.  Strong Enrichment of Aromatic Residues in Binding Sites from a Charge-neutralized Hyperthermostable Sso7d Scaffold Library.

Authors:  Michael W Traxlmayr; Jonathan D Kiefer; Raja R Srinivas; Elisabeth Lobner; Alison W Tisdale; Naveen K Mehta; Nicole J Yang; Bruce Tidor; K Dane Wittrup
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.